A Day Up For VistaGen Therapeutics, Inc.
VistaGen Therapeutics, Inc. (VTGN:NASDAQ) jumped higher at $0.18, a gain of 27.2%. The stock appeared on our News Catalysts scanner on Tue, Feb 07, 2023 at 04:53 PM in the 'INVESTOR UPDATE' category. From Fri, Jan 27, 2023, the stock recorded 60.00% Up Days and 63.64% Green Days
The stock spiked on Mon, Feb 06, 2023 at $0.34 with a volume of 12M+.
About VistaGen Therapeutics, Inc. (VTGN:NASDAQ)
VistaGen Therapeutics Inc is a clinical-stage biopharmaceutical company that develops and commercializes product candidates for patients with central nervous system diseases. Its product AV-101 is currently being evaluated in a Phase 2 monotherapy study.
Top 10 Gainers:
- Allied Healthcare Products, Inc. (AHPI:NASDAQ), 400%
- Vallon Pharmaceuticals Inc. (VLON:NASDAQ), 72.57%
- SeqLL Inc. (SQL:NASDAQ), 57.14%
- Expion360 Inc. (XPON:NASDAQ), 55.56%
- FLJ Group Limited (FLJ:NASDAQ), 44.95%
- Hillstream BioPharma Inc. (HILS:NASDAQ), 34.75%
- Oriental Culture Holding LTD (OCG:NASDAQ), 33.35%
- Oscar Health Inc. Class A (OSCR:NYSE), 30.26%
- VistaGen Therapeutics, Inc. (VTGN:NASDAQ), 27.19%
- NeuBase Therapeutics, Inc. (NBSE:NASDAQ), 26.92%